Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
Netflix
NFLX
|
+$753M |
| 3 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$749M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$662M |
| 5 |
Walmart Inc
WMT
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$426M |
| 3 |
Meta Platforms (Facebook)
META
|
+$372M |
| 4 |
TSMC
TSM
|
+$331M |
| 5 |
Pinduoduo
PDD
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.23% |
| 2 | Technology | 1.7% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Communication Services | 0.67% |
| 5 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11826
CALL
TherapeuticsMD
TXMD
$25.7M
| $39.3K | ﹤0.01% |
+24,100
| New | +$34.8K |
|
|
NVX
11827
PUT
NOVONIX
NVX
$901M
| $39K | ﹤0.01% |
+3,860
| New | +$54.8K |
|
11828
Fenbo Holdings
FEBO
$7.96M
| $38.7K | ﹤0.01% |
28,661
+2,661
| +10% | +$2.27K |
|
11829
PUT
Gerdau
GGB
$9.22B
| $38.4K | ﹤0.01% |
+10,400
| New | +$36.3K |
|
|
HUYA
11830
PUT
Huya Inc
HUYA
$493M
| $38.3K | ﹤0.01% |
13,300
-7,679,700
| -100% | -$22.5M |
|
11831
CALL
Neuronetics
STIM
$226M
| $38K | ﹤0.01% |
27,500
-2,400
| -8% | -$5.02K |
|
11832
CALL
Nano X Imaging
NNOX
$66.2M
| $37.5K | ﹤0.01% |
+13,400
| New | +$48.2K |
|
|
PGYWW
11833
Pagaya Technologies Ltd Warrants
PGYWW
$904K
| $37.5K | ﹤0.01% |
117,202
+24,911
| +27% | +$10.7K |
|
|
IMMP
11834
CALL
Immutep
IMMP
$56.1M
| $37.5K | ﹤0.01% |
+13,100
| New | +$27.6K |
|
11835
Veru
VERU
$46.7M
| $37.4K | ﹤0.01% |
17,491
-49,438
| -74% | -$147K |
|
11836
CALL
Aclaris Therapeutics
ACRS
$907M
| $37.3K | ﹤0.01% |
+12,400
| New | +$31.3K |
|
11837
PUT
Stereotaxis
STXS
$147M
| $37.3K | ﹤0.01% |
+16,200
| New | +$43.1K |
|
|
LPRO
11838
DELISTED
Open Lending Corp
LPRO
| $37.2K | ﹤0.01% |
24,008
-36,986
| -61% | -$65.6K |
|
|
OGI
11839
CALL
Organigram Holdings
OGI
$173M
| $37.1K | ﹤0.01% |
22,100
-93,000
| -81% | -$160K |
|
11840
Biote Corp
BTMD
$46.7M
| $37K | ﹤0.01% |
+14,238
| New | +$38.9K |
|
11841
PUT
Tenaya Therapeutics
TNYA
$156M
| $36.4K | ﹤0.01% |
51,300
+2,200
| +4% | +$2.99K |
|
11842
Evotec
EVO
$700M
| $36.4K | ﹤0.01% |
+11,822
| New | +$40.6K |
|
11843
PUT
Magnachip Semiconductor
MX
$118M
| $36.2K | ﹤0.01% |
+14,200
| New | +$39.5K |
|
11844
Cellectar Biosciences
CLRB
$24M
| $36K | ﹤0.01% |
+12,204
| New | +$45.1K |
|
11845
PUT
Wrap Technologies
WRAP
$106M
| $35.2K | ﹤0.01% |
+14,800
| New | +$35.7K |
|
11846
LiqTech
LIQT
$18.5M
| $35.2K | ﹤0.01% |
+24,095
| New | +$52.2K |
|
11847
CALL
SmartRent
SMRT
$261M
| $35.1K | ﹤0.01% |
17,400
-8,800
| -34% | -$14.4K |
|
|
FARM
11848
DELISTED
Farmer Brothers
FARM
| $34.8K | ﹤0.01% |
+23,815
| New | +$38.4K |
|
11849
Retractable Technologies
RVP
$21.6M
| $34.7K | ﹤0.01% |
44,901
-9,645
| -18% | -$8.32K |
|
11850
PUT
Goldgroup Mining
GORO
$511M
| $34.4K | ﹤0.01% |
41,500
-3,100
| -7% | -$2.47K |
|
Similar funds
Jeff Yass's Q4 2025 Portfolio in Review
As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
- Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
- Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
- Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
- Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
- Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.